This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: International Institute of Cancer Immunology, Inc., Otsuka Pharmaceutical Company, Limited. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020-2025
Title: Innovator Masayoshi Sato: Pioneering Advances in T Cell Activation
Introduction: Masayoshi Sato, based in Osaka, Japan, is an influential inventor who has made significant contributions to the field of immunology. His innovative methods focus on the activation of helper T cells, which play a critical role in the immune system. With a dedication to advancing scientific research, Sato has earned recognition for his pioneering work.
Latest Patents: Sato holds a patent for a "Method for Activating Helper T Cells." This invention describes a method for activating helper T cells that involves adding a WT1 peptide to antigen-presenting cells. The WT1 peptide is uniquely suited to bind with various MHC class II molecules, including several HLA-DRB1 and HLA-DPB1 alleles, thereby enhancing the immune response.
Career Highlights: Throughout his career, Masayoshi Sato has been associated with reputed organizations that focus on cancer immunology and pharmaceuticals. He has worked at the International Institute of Cancer Immunology, Inc. and Otsuka Pharmaceutical Company, Limited. His experience in these institutions has contributed to his expertise and innovation in his field.
Collaborations: Sato has collaborated with notable colleagues, including Haruo Sugiyama and Shinji Sogo. Working together, they have contributed to breakthroughs in understanding and manipulating immune responses.
Conclusion: Masayoshi Sato's work exemplifies the spirit of innovation in the field of immunology. With a patented method for activating helper T cells and collaborations with esteemed professionals, he continues to influence cancer research and the development of therapeutic approaches. His dedication to science and innovation serves as an inspiration for future inventors in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile